<- Go Home

Cholestech Corporation

Cholestech Corporation was acquired by Alere Inc. Cholestech Corporation manufactures and distributes diagnostic tools and point-of-care testing applications for immediate risk assessment and therapeutic monitoring of heart disease, inflammatory disorders, and diabetes. Its products include Cholestech LDX system that provides results for lipids, glucose, liver enzymes, and high sensitivity C-reactive protein at the point-of-care; Cholestech GDX, an A1C testing system that enables to monitor HbA1c levels as a measure of long-term glycemic control with a finger stick test. The company was founded in 1988 and is based in San Diego, California.

Market Cap

$330.3M

Volume

146.2K

Cash and Equivalents

$7.6M

EBITDA

$14.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$47.0M

Profit Margin

66.38%

52 Week High

$23.16

52 Week Low

$11.80

Dividend

N/A

Price / Book Value

3.38

Price / Earnings

33.66

Price / Tangible Book Value

3.40

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$12.1M

Return on Equity

11.31%

Return on Assets

8.05

Cash and Short Term Investments

$50.2M

Debt

N/A

Equity

$97.5M

Revenue

$70.9M

Unlevered FCF

$9.2M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches